Outcomes of Pulmonary Valve Replacement for Correction Pulmonary Insufficiency after Primary Repair of Tetralogy of Fallot (TOF)

سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 366

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_INJPM-4-9_018

تاریخ نمایه سازی: 20 مهر 1398

چکیده مقاله:

Background Total correction of Tetralogy of Fallot (TOF) anomaly in early childhood has been practiced in many centers with good results, but in some of patients after few years sever Pulmonary valve insufficiency occurred. Materials and Methods At a cross- sectional study from January 2015 to January 2016, 10 patients who had history of primary repair of TOF with free pulmonary insufficiency (PI) that underwent of pulmonary valve replacement (PVR) with bioprosthetic valves were evaluated. Results Themean age of patients was 6.5 + 0.753 years old (ranged 8-12 years old) and male to female ratio was 6/4. The mean of Intensive care unit (ICU) stay and Hospital stay was 4.5+ 0.712 days (ranged 3-8) and 11.5+ 0.357 days (ranged 9- 16). Mean of cardiopulmonary bypass time and operation time was 45 + 0.684 min (ranged 32-60) and 83 + 0.317 min (ranged 65-112). In this study we did not find any mortality and ventricular arrhythmia and Heart block. There was only one case (10%) with superficial wound infection that was controlled. At 6 months follow up, all of patients were alive, but Echocardiography sign of Right Ventricular (RV) failure was present in 2 patients (20%) recently. Conclusion Although for Pulmonary insufficiency after primary TOF repair there is controversial in studies, but we had good results of PVR with Bioprosthesis in TOF patients.

نویسندگان

Mohammad Abbassi Teshnisi

Associated Professor, Department of Cardiac Surgery, Atherosclerosis Prevention Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Iran

Aliasghar Moeinipour

Assistant Professor, Department of Cardiac Surgery, Atherosclerosis Prevention Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Hamid Hoseinikhah

Assistant Professor, Department of Cardiac Surgery, Atherosclerosis Prevention Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyedeh Zahra Aemmi

MSN, Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.